◆英語タイトル:Sartorius AG (SRT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011034
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.
Sartorius AG (SRT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sartorius AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sartorius AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sartorius AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sartorius AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sartorius AG, Medical Equipment, Deal Details 11
Venture Financing 11
IntelliCyt Raises USD5.4 Million in Venture Financing Round 11
IntelliCyt Raises USD0.05 Million in Venture Financing 12
IntelliCyt Raises US$8.4 Million In Series B Financing 13
ViroCyt Raises Funds In Second Round Of Growth Financing 14
Partnerships 15
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 15
Notable Labs Enters into Agreement with IntelliCyt 16
Genedata Enters into Integration Agreement with IntelliCyt 17
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 18
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 19
Sartorius Stedim Enters Into An Agreement With RAUMEDIC 20
Acquisition 21
Sartorius Acquires Essen BioScience for USD320 Million 21
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 22
Sartorius Acquires ViroCyt for USD18.5 Million 23
Sartorius Acquires IntelliCyt for USD103.8 Million 24
Sartorius AG – Key Competitors 25
Sartorius AG – Key Employees 26
Sartorius AG – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Strategy And Business Planning 30
Jul 18, 2016: Sartorius Expands Production Site in England 30
Financial Announcements 31
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 31
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 33
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 34
Feb 23, 2017: Sartorius Reviews Fiscal 2016 35
Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017 37
Oct 24, 2016: Nine-month Figures for 2016: Sartorius Continues to Grow by Strong Double Digits 39
Jul 25, 2016: Business Figures for the First Half of 2016: Sartorius Continues to Grow by Strong Double Digits 40
Apr 20, 2016: Q1 Results: Sartorius Off to a Dynamic Start in 2016 42
Feb 26, 2016: Sartorius Reviews Fiscal 2015 Results 43
Feb 01, 2016: Sartorius Grows by Double Digits in Sales and Profit in 2015 – Positive Outlook for 2016 – Targets for 2020 Updated 45
Corporate Communications 46
Mar 09, 2017: Sartorius appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for its Laboratory Division 46
Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 47
Other Significant Developments 48
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
Sartorius AG, Medical Equipment, Key Facts, 2016 2
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sartorius AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sartorius AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sartorius AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sartorius AG, Deals By Market, 2011 to YTD 2017 9
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
IntelliCyt Raises USD5.4 Million in Venture Financing Round 11
IntelliCyt Raises USD0.05 Million in Venture Financing 12
IntelliCyt Raises US$8.4 Million In Series B Financing 13
ViroCyt Raises Funds In Second Round Of Growth Financing 14
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 15
Notable Labs Enters into Agreement with IntelliCyt 16
Genedata Enters into Integration Agreement with IntelliCyt 17
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 18
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 19
Sartorius Stedim Enters Into An Agreement With RAUMEDIC 20
Sartorius Acquires Essen BioScience for USD320 Million 21
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 22
Sartorius Acquires ViroCyt for USD18.5 Million 23
Sartorius Acquires IntelliCyt for USD103.8 Million 24
Sartorius AG, Key Competitors 25
Sartorius AG, Key Employees 26
Sartorius AG, Other Locations 27
Sartorius AG, Subsidiaries 27